Paul M. Lieberman

Wistar Institute

NIH Rank #4166
  • Program Leader
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$2.3M
Fiscal year 2024
Grants Awarded
6
Active NIH grants
National Rank
#4,166
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.3M across 6 grants · National rank #4166.

Top grants by award amount

Paul M. Lieberman's NIH grant portfolio, ranked by award amount.

  • 5R01CA282411-02R01
    EBNA1 Inhibitor for Treatment of EBV-positive DLBCL
    $505.6K
    award amount
  • 5P01CA281867-02P01
    Transcription and Replication of Oncogenic Viruses in Hypoxia
    $424.5K
    award amount
  • 5R01CA140652-14R01
    Role of TERRA in Telomere Maintenance and Telomere Stress Response
    $413K
    award amount
  • 5R01CA117830-17R01
    Epigenomic Control of KSHV Latency
    $410.2K
    award amount
  • 5R01DE017336-16R01
    Epigenetic Regulation of Epstein-Barr Virus
    $357.3K
    award amount
  • 5P01CA269043-02P01
    Targeting the Epigenetic and Metabolic Control of EBV-Epithelial Cancers
    $200.2K
    award amount

Affiliations

Institutions that have administered grants for Paul M. Lieberman.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Wistar Institute
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4166
  6. 2024
    Entered Top 25% Nationally
    Ranked #4166
  7. 2024
    Multi-Institutional Research
    Awards at 2 institutions